Organization
Montefiore Einstein Comprehensive Cancer Center/Albert Einstein College of Medicine
4 abstracts
Abstract
Repurposing hemostatic drug desmopressin in AVPR2-expressing triple-negative breast cancer: Target expression analysis and preclinical antineoplastic effects on tumor growth and metastatic progression.Org: Center of Translational Medicine, El Cruce “Néstor Kirchner” Hospital, Montefiore Einstein Comprehensive Cancer Center/Albert Einstein College of Medicine, Center for Molecular and Translational Oncology (COMTra), Science and Technology Department, National University of Quilmes, Provincial Institute for Cancer Prevention and Treatment (IPC),
Abstract
Metabolic profile and therapeutic vulnerabilities of multi-omic characterization of KRAS/STK11/KEAP1 co-mutant non–small cell lung cancer (NSCLC).Org: Caris Life Sciences, Irving, TX, Penn State Milton S. Hershey Medical Center, Hershey, PA, Caris Life Sciences Research and Development, Montefiore Einstein Comprehensive Cancer Center/Albert Einstein College of Medicine,
Abstract
PD-L1 and alternative immune checkpoints (AICs) in non-small cell lung cancer (NSCLC): Insights into the tumor immune microenvironment (TIME) and immunotherapy (IO) outcomes.Org: Montefiore Einstein Comprehensive Cancer Center/Albert Einstein College of Medicine, Caris Life Sciences, Irving, TX, Fox Chase Cancer Center, Lombardi Comprehensive Cancer Center, Georgetown University Medical School,
Abstract
Short-term and long-term survival outcomes in patients with invasive lobular carcinoma vs. invasive ductal carcinoma of the breast.Org: Montefiore Einstein Comprehensive Cancer Center/Albert Einstein College of Medicine, Albert Einstein College of Medicine,